Government
Every published round National Health & Medical Research Council took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies National Health & Medical Research Council has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for National Health & Medical Research Council, as distinct from the investments it has made.
Companies National Health & Medical Research Council has backed that another company then bought. An exit for the holding, not a deal National Health & Medical Research Council did.
Stories naming National Health & Medical Research Council. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of brief items: Memphasys hails fertility device trial results; a concrete recycler is fined; Wurrba, Hazer and University of Queensland land government grants; Aus J gains a North American distribution partner.
ANDHealth supports the Australian government's new national health research strategy and funding commitments, highlighting the role of its accelerator in driving digital health innovation.
Profile of Sydney genomics startup 23Strands, covering its university and research collaborations, a $1 million grant, an NHMRC-backed project, and its 2020 UNSW Health10X accelerator background.
Techboard's monthly roundup logs June 2022 Australian funding events, including GO1's Series E, Edrolo's Series B, two acquisitions, several new funds reaching closes, and accelerator intake announcements.
Also Techboard
Melbourne biotech Hatchtech received two $10,000 Australian commercialisation prizes and had recently drawn down extra funding to sit alongside its $2.4 million government grant for its head lice treatment.